Clinical Trials Browser

Phase 1/2 × Keratosis, Actinic × methyl 5-aminolevulinate × Clear all

NCT02149342 2016-07-11

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Phase 1/2 Completed

14 enrolled 8 charts

Keratosis, Actinic